artenimol has been researched along with Osteolysis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, HX; Fan, YY; Feng, MX; Hong, D; Hong, JX; Lei, XH; Qin, A; Wang, Q; Yuan, CT; Zhu, M | 1 |
1 other study(ies) available for artenimol and Osteolysis
Article | Year |
---|---|
Dihydroartemisinin prevents breast cancer-induced osteolysis via inhibiting both breast caner cells and osteoclasts.
Topics: Actins; Animals; Artemisinins; Bone Density; Breast Neoplasms; Cell Differentiation; Cell Line, Tumor; Cell Movement; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Inbred C57BL; Osteoblasts; Osteoclasts; Osteolysis; Proto-Oncogene Proteins c-akt; Signal Transduction; src-Family Kinases; Titanium; Xenograft Model Antitumor Assays | 2016 |